Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
The potential of adjuvant mRNA–lipoplex neoantigen vaccines to induce durable ... vaccines prime long-lived CD8+ T cells in pancreatic cancer, Nature (2025). DOI: 10.1038/s41586-024-08508-4 ...
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small ...
FRIDAY, Feb. 21, 2025 (HealthDay News) -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...